The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Abdulamir, A S ^a   Hafidh, R R ^a   Abdulmuhaimen, N ^b   Abubakar, F ^a,b   Abbas, K A ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b AL NAHRAIN UNIVERSITY   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS T ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ANTIBODY BLOOD LEVEL; ARTICLE; ATTRIBUTABLE RISK; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FAMILY HISTORY; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; RISK FACTOR; SEX DIFFERENCE; SMOKING; AGE; BLOOD; COMPARATIVE STUDY; DRINKING BEHAVIOR; HYPOPHARYNX TUMOR; IMMUNOLOGY; INCIDENCE; IRAQ; ISOLATION AND PURIFICATION; JORDAN; LARYNX TUMOR; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; IRAQ; JORDAN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RISK FACTORS; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 58149289554     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-400     Document Type: Article

References (28)

1. Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. HS Erkal M Serin A Cakmak, Radiother Oncol 2001 61 3 247 56 10.1016/S0167-8140(01)00448-0 11730993
2. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. JS Cooper H Lee M Torrey H Hochster, Int J Radiat Oncol Biol Phys 2000 47 4 861 6 10863053
3. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. RD Burt TL Vaughan B McKnight, Int J Cancer 1992 52 4 549 56 10.1002/ijc.2910520409 1399135
4. Epidemiology of nasopharyngeal carcinoma. MC Yu JM Yuan, Semin Cancer Biol 2002 12 6 421 9 10.1016/S1044579X02000858 12450728
5. Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. P Busson T Ooka M Corbex, Med Sci (paris) 2004 20 4 453 7 15124119
6. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. SH Ou JA Zell A Ziogas H Anton-Culver, Ann Oncol 2007 18 1 29 35 10.1093/annonc/mdl320 17060483
7. Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. WT Ng CW Choi MC Lee SH Chan TK Yau AW Lee, Fam Cancer 2008 18726711
8. Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. H Akeshita M Furukawa S Fujieda H Shoujaku T Ookura M Sakaguchi H Ito H Mineta T Harada H Matsuura, Auris Nasus Larynx 1999 26 3 277 86 10.1016/S0385-8146(98)00080-7 10419035
9. Annual Iraqi cancer registry bulletin. Iraqi cancer Board, 2003
10. Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection. JG Tang Xuan Li P Cheng, J Zhejiang Univ SCI 2004 5 10 1304 1312 15362205 10.1631/jzus.2004.1304
11. Infection with Epstein-Barr virus and cancer: an epidemiological review. D Serraino P Piselli C Angeletti M Scuderi G Ippolito MR Capobianchi, J Biol Regul Homeost Agents 2005 19 1-2 63 70 16178276
12. The role of Epstein-Barr virus in cancer. SB Pattle PJ Farrell, Expert Opin Biol Ther 2006 6 11 1193 205 10.1517/14712598.6.11.1193 17049016
13. The Epstein-Barr virus and its association with human cancers. KR Baumforth LS Young KJ Flavell C Constandinou PG Murray, Mol Pathol 1999 52 6 307 322 10748864 10.1136/mp.52.6.307
14. TNM Classification of Malignant Tumors. UICC, 3 1978
15. Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. I Wakabayashi R Kobaba-Wakabayashi H Masuda, Diabetes Care 2002 25 7 1223 1228 10.2337/diacare.25.7.1223 12087023
16. Enzyme innunoassay. A Schuurs V Weeman, Clin Chem Acta 1977 31 4 1 40 10.1016/0009-8981(77)90410-7
17. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. WM Cheng KH Chan HL Chen RX Luo SP Ng W Luk BJ Zheng MF Ji JS Liang JS Sham, Int J Cancer 2002 97 4 489 492 10.1002/ijc.1641 11802211
18. Epstein-Barr virus serology and gastric cancer incidence and survival. J Koshiol YL Qiao SD Mark SM Dawsey CC Abnet F Kamangar ET Lennette ZW Dong PR Taylor, Br J Cancer 2007 97 11 1567 1569 10.1038/sj.bjc.6604063 17987041
19. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Fachiroh T Schouten B Hariwiyanto DK Paramita A Harijadi SM Haryana MH Ng JM Middeldorp, J Infect Dis 2004 190 1 53 62 10.1086/421245 15195243
20. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. KH Chan YL Gu F Ng PS Ng WH Seto JS Sham D Chua W Wei YL Chen W Luk, Int J Cancer 2003 105 5 706 709 10.1002/ijc.11130 12740922
21. Head and neck cancer: a global perspective on epidemiology and prognosis. R Sankaranarayanan E Masuyer R Swaminathan J Ferlay S Whelan, Anticancer Res 1998 18 6B 4779 4786 9891557
22. Epstein-Barr virus and oncogenesis: from latent genes to tumours. LS Young PG Murray, Oncogene 2003 22 33 5108 5121 10.1038/sj.onc.1206556 12910248
23. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. F Berrino G Gatta, Eur J Cancer 1998 34 14 2154 2161 10.1016/S0959-8049(98)00328-1
24. Health impact of head and neck cancer. JE Terrell K Nanavati RM Esclamado CR Bradford GT Wolf, Otolaryngol-Head-Neck-Surg 1999 120 6 852 9 10.1016/S0194-5998(99)70326-8 10352439
25. The enigmatic epidemiology of nasopharyngeal carcinoma. ET Chang HO Adami, Cancer Epidemiol Biomarkers Prev 2006 15 10 1765 1777 10.1158/1055-9965.EPI-06-0353 17035381
26. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. YS ong JS Sham MH Ng XT Ou YQ Guo SA Zheng JS Liang H Qiu, Cancer 1992 69 1 3 7 10.1002/1097-0142(19920101)69:1<3::AID- CNCR2820690104>3.0.CO;2-7 1309307
27. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. R Feinmesser I Miyazaki R Cheung JL Freeman AM Noyek HM Dosch, N Engl J Med 1992 326 1 17 21 1309196
28. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. H Zheng LL Li DS Hu XY Deng Y Cao, Cell Mol Immunol 2007 4 3 185 196 17601372